Skip to content
You can now search across every topic, entity and event.What's new
UK Startups and Innovation
21SEP

Claret closes €575m debt fund

1 min read
16:52UTC

Claret Capital Partners closed a €575 million growth debt fund on 7 September, a 94% step-up on the €297 million it raised for the predecessor fund in 2022.

TechnologyDeveloping
Key takeaway

European growth debt capacity has nearly doubled since 2022 at this one lender.

Claret Capital Partners closed a €575 million growth debt fund on 7 September, a 94% step-up on the €297 million it raised for the predecessor fund in 2022 1. Growth debt lends against future revenue rather than against assets, so a company borrows without issuing shares and without a valuation event. Claret joined the Open Cosmos syndicate announced a week later, which is the pattern the instrument suits: a company with revenue history that wants capital without dilution. The British Business Bank reached the same instrument from the other end in July, proposing a debt fund for aerospace suppliers rather than an equity one . Doubling a fund of this kind in four years says the European lenders now believe there are enough such companies to lend to, which is a quieter claim about the market than any equity round makes, and a more testable one.

Deep Analysis

In plain English

Claret Capital Partners, the same firm that took part in Open Cosmos's funding round, has finished raising a €575m fund. Unlike a normal investment fund that buys shares in companies, this one lends money to growing companies, a type of financing called venture debt. The new fund is almost double the size of the firm's previous one, which closed at €297m in 2022, suggesting lenders see more demand for this kind of loan from growth-stage European companies than they did four years ago.

First Reported In

Update #15 · Nscale takes $103.4bn of contracts to NYSE

Claret Capital Partners· 21 Sept 2026
Read original
Different Perspectives
Nscale and Open Cosmos
Nscale and Open Cosmos
Nscale chose the New York Stock Exchange for its listing on 18 September, putting Britain's largest AI infrastructure bet to American public investors rather than British ones. Open Cosmos took the opposite route four days earlier, raising nine figures from an all-domestic syndicate on five years of profit, evidence that staying is possible when the balance sheet allows it.
Dame Chi Onwurah and the Science, Innovation and Technology Committee
Dame Chi Onwurah and the Science, Innovation and Technology Committee
Committee chair Dame Chi Onwurah wrote to government on 7 September asking how Matt Clifford's conflict at ARIA arose and what safeguards protect its governance, and expects a detailed response. Her question has not yet been put to the Sovereign AI Unit, whose own chair sits at a venture capital firm while overseeing state AI equity.
The Entrepreneurs Network
The Entrepreneurs Network
The Entrepreneurs Network's founder survey found 65% say Britain is easy to start a business in but only 14% say it is easy to scale one, with 82% negative on tax and 74% finding investment hard to access. On this reading the constraint is regulation and tax, not the capital-vehicle design the state keeps adjusting.
New Economics Foundation
New Economics Foundation
The New Economics Foundation argues fiscal accounting rules, not political will, cap what Britain's state capital vehicles can do. Matching the KfW and Bpifrance benchmark of 1% of GDP would need the National Wealth Fund to deploy roughly GBP21bn a year by 2028-29, about four times its current capacity.
Competition and Markets Authority
Competition and Markets Authority
The CMA's 8 September report on public procurement asked whether Britain's roughly GBP400bn state-spending system is built to grow high-potential firms rather than simply widen SME participation. Its Recommendation 5 calls for a dedicated frontier-technology procurement framework, an official acknowledgement that today's design may serve the wrong target.
Highland Europe
Highland Europe
Highland Europe, the growth-equity firm behind a €1bn-plus fund, took €65m from the British Business Bank into its Technology Growth Fund VI on 30 July via British Patient Capital. For a Geneva-based growth investor, the Bank's cheque is routine cornerstone capital, unrelated to which Whitehall department currently claims to sponsor UKRI.